tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Cholangitis, Sclerosing D015209 1 associated lipids
Hepatic Insufficiency D048550 1 associated lipids
Lung Abscess D008169 1 associated lipids
Central Nervous System Viral Diseases D020805 1 associated lipids
Facial Nerve Injuries D020220 1 associated lipids
Intertrigo D007402 1 associated lipids
Miller Fisher Syndrome D019846 1 associated lipids
Mediastinal Emphysema D008478 1 associated lipids
Angiolymphoid Hyperplasia with Eosinophilia D000796 1 associated lipids
Eye Infections, Viral D015828 1 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Hatanaka H and Shimomura K [Immunosuppressive activity of a microbial product]. 1997 Nippon Yakurigaku Zasshi pmid:9503409
Milićević NM and Milićević Z Stereological study of splenic tissue compartments in FK506-treated rats. 1997 Histol. Histopathol. pmid:9302561
Wingard JR et al. Lack of interaction between tacrolimus (FK506) and methotrexate in bone marrow transplant recipients. 1997 Bone Marrow Transplant. pmid:9232256
Yamagami S et al. Mechanism of concordant corneal xenograft rejection in mice: synergistic effects of anti-leukocyte function-associated antigen-1 monoclonal antibody and FK506. 1997 Transplantation pmid:9233699
Wijnen RM and Ericzon BG Update of tacrolimus in pancreas transplantation. 1997 Diabet. Med. pmid:9400914
Sawabe T et al. Sinus arrest during tacrolimus (FK506) and digitalis treatment in a bone marrow transplant recipient. 1997 Transplantation pmid:9233725
Misao T et al. Efficacy of combining donor-specific presensitization with a simultaneous single injection of tacrolimus on pulmonary allografts. 1997 J. Heart Lung Transplant. pmid:9402508
Suzuki J et al. Inhibition of accelerated coronary atherosclerosis with short-term blockade of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 in a heterotopic murine model of heart transplantation. 1997 J. Heart Lung Transplant. pmid:9402514
Cohen SB et al. Autocrine and paracrine regulation of human T cell IL-10 production. 1997 J. Immunol. pmid:9190906
Zucker K et al. Unexpected augmentation of mycophenolic acid pharmacokinetics in renal transplant patients receiving tacrolimus and mycophenolate mofetil in combination therapy, and analogous in vitro findings. 1997 Transpl. Immunol. pmid:9402690
Miyata Y et al. Phosphorylation of the immunosuppressant FK506-binding protein FKBP52 by casein kinase II: regulation of HSP90-binding activity of FKBP52. 1997 Proc. Natl. Acad. Sci. U.S.A. pmid:9405642
Taylor DO The use of tacrolimus and mycophenolate mofetil after cardiac transplantation. 1997 Curr. Opin. Cardiol. pmid:9192485
Harihara Y and Makuuchi M [Partial liver transplantation]. 1997 Nippon Naika Gakkai Zasshi pmid:9340350
Hayashi S et al. Adenovirus-mediated gene transfer to the xenogeneic liver in liver xenotransplantation: the transduction of complement regulatory factor genes (DAF and HRF20). 1997 Transplant. Proc. pmid:9193595
Wallemacq PE et al. IMx tacrolimus II vs IMx tacrolimus microparticle enzyme immunoassay evaluated in renal and hepatic transplant patients. 1997 Clin. Chem. pmid:9342026
Hohage H et al. Effects of cyclosporin A and FK 506 on lipid metabolism and fibrinogen in kidney transplant recipients. 1997 Clin Transplant pmid:9193847
Gold BG et al. A nonimmunosuppressant FKBP-12 ligand increases nerve regeneration. 1997 Exp. Neurol. pmid:9344552
de Paulis A et al. Human synovial mast cells. II. Heterogeneity of the pharmacologic effects of antiinflammatory and immunosuppressive drugs. 1997 Arthritis Rheum. pmid:9082935
Moroda T et al. Self-reactive forbidden clones are confined to pathways of intermediate T-cell receptor cell differentiation even under immunosuppressive conditions. 1997 Immunology pmid:9203970
Spencer CM et al. Tacrolimus. An update of its pharmacology and clinical efficacy in the management of organ transplantation. 1997 Drugs pmid:9421697
Mrvos R et al. Tacrolimus (FK 506) overdose: a report of five cases. 1997 J. Toxicol. Clin. Toxicol. pmid:9204100
Stegall MD et al. Mycophenolate mofetil decreases rejection in simultaneous pancreas-kidney transplantation when combined with tacrolimus or cyclosporine. 1997 Transplantation pmid:9422404
Sikorski R and Peters R A cell growth switch. 1997 Science pmid:9206844
Shield CF et al. Assessment of health-related quality of life in kidney transplant patients receiving tacrolimus (FK506)-based versus cyclosporine-based immunosuppression. FK506 Kidney Transplant Study Group. 1997 Transplantation pmid:9422413
Shafiee A et al. Chemical and biological characterization of two FK506 analogs produced by targeted gene disruption in Streptomyces sp. MA6548. 1997 J. Antibiot. pmid:9207912
Stegall MD et al. Prednisone withdrawal 14 days after liver transplantation with mycophenolate: a prospective trial of cyclosporine and tacrolimus. 1997 Transplantation pmid:9422416
Uberti JP et al. Tacrolimus and methotrexate for the prophylaxis of acute graft-versus-host disease in allogeneic bone marrow transplantation in patients with hematologic malignancies. 1997 Bone Marrow Transplant. pmid:9208118
Shihab FS et al. Mechanism of fibrosis in experimental tacrolimus nephrotoxicity. 1997 Transplantation pmid:9422427
Ohashi Y et al. Successful treatment of steroid-resistant severe acute GVHD with 24-h continuous infusion of FK506. 1997 Bone Marrow Transplant. pmid:9085743
Vu MD et al. Tacrolimus (FK506) and sirolimus (rapamycin) in combination are not antagonistic but produce extended graft survival in cardiac transplantation in the rat. 1997 Transplantation pmid:9422432
Oz HS and Hughes WT Novel anti-Pneumocystis carinii effects of the immunosuppressant mycophenolate mofetil in contrast to provocative effects of tacrolimus, sirolimus, and dexamethasone. 1997 J. Infect. Dis. pmid:9086147
Wagner K et al. New-onset diabetes mellitus in pediatric thoracic organ recipients receiving tacrolimus-based immunosuppression. 1997 J. Heart Lung Transplant. pmid:9087870
Yasutomi M et al. Evaluation of tetrahydropyranyladriamycin as an immunosuppressant in concordant xenotransplantation. 1997 J. Heart Lung Transplant. pmid:9087871
Kitagaki K et al. Facilitation of apoptosis by cyclosporins A and H, but not FK506 in mouse bronchial eosinophils. 1997 Eur. J. Pharmacol. pmid:9430427
Morrissey PE et al. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria. 1997 Transplantation pmid:9089224
Midtvedt K et al. Successful pregnancies in a combined pancreas and renal allograft recipient and in a renal graft recipient on tacrolimus treatment. 1997 Nephrol. Dial. Transplant. pmid:9430893
Kiuchi T et al. A hepatic graft tuberculosis transmitted from a living-related donor. 1997 Transplantation pmid:9089234
Paterson DL and Singh N Interactions between tacrolimus and antimicrobial agents. 1997 Clin. Infect. Dis. pmid:9431391
Steffen R et al. Autoimmune enteropathy in a pediatric patient: partial response to tacrolimus therapy. 1997 Clin Pediatr (Phila) pmid:9152557
Chow FS et al. Effect of hematocrit and albumin concentration on hepatic clearance of tacrolimus (FK506) during rabbit liver perfusion. 1997 Drug Metab. Dispos. pmid:9152601
Woo M et al. Toxicities of tacrolimus and cyclosporin A after allogeneic blood stem cell transplantation. 1997 Bone Marrow Transplant. pmid:9466284
Araki T et al. Effects of vinconate on age-related alterations in [3H]MK-801, [3H]glycine, sodium-dependent D-[3H]aspartate, [3H]FK-506 and [3H]PN200-110 binding in rats. 1997 Mech. Ageing Dev. pmid:9152958
Banholzer R et al. Rapamycin destabilizes interleukin-3 mRNA in autocrine tumor cells by a mechanism requiring an intact 3' untranslated region. 1997 Mol. Cell. Biol. pmid:9154824
Delehanty LL et al. Apoptosis in a Fas-resistant, T-cell receptor-sensitive human leukaemic T-cell clone. 1997 Immunology pmid:9155645
Newell KA et al. Treatment with either anti-CD4 or anti-CD8 monoclonal antibodies blocks alphabeta T cell-mediated rejection of intestinal allografts in mice. 1997 Transplantation pmid:9381541
Iyengar AR et al. Striking augmentation of hematopoietic cell chimerism in noncytoablated allogeneic bone marrow recipients by FLT3 ligand and tacrolimus. 1997 Transplantation pmid:9158008
van Hooff JP Pneumocystis carinii pneumonia after renal transplantation. 1997 Transplantation pmid:9158038
Siddiqui MA et al. Lymphomatoid papulosis and FK 506. 1997 Int. J. Dermatol. pmid:9159004
Okudaira H et al. Control of allergic diseases by regulation of cytokine gene transcription. 1997 Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M pmid:9383912
Lee JW et al. Tacrolimus (FK506): validation of a sensitive enzyme-linked immunosorbent assay kit for and application to a clinical pharmacokinetic study. 1997 Ther Drug Monit pmid:9108651
Thyagarajan GK et al. FK506-induced fulminant leukoencephalopathy after single-lung transplantation. 1997 Ann. Thorac. Surg. pmid:9386723
Hickman PE et al. Clinical chemistry and post-liver-transplant monitoring. 1997 Clin. Chem. pmid:9265907
Tomás ML [Immunosuppressive agents: side effects]. 1997 An R Acad Nac Med (Madr) pmid:9616947
Aicher L et al. Decrease in kidney calbindin-D 28kDa as a possible mechanism mediating cyclosporine A- and FK-506-induced calciuria and tubular mineralization. 1997 Biochem. Pharmacol. pmid:9113092
Paterson DL et al. Could a herpesvirus mimic tacrolimus-induced leukoencephalopathy? 1997 Ann. Neurol. pmid:9266742
Ahsan N et al. Successful reversal of acute vascular rejection in a renal allograft with combined mycophenolate mofetil and tacrolimus as primary immunotherapy. 1997 Clin Transplant pmid:9113443
Yoshimoto T et al. [Leukoencephalopathy probably caused by tacrolimus hydrate after stem cell transplantation in a girl with MDS 7 monosomy]. 1997 Rinsho Ketsueki pmid:9267167
Singh N et al. Invasive fungal infections in liver transplant recipients receiving tacrolimus as the primary immunosuppressive agent. 1997 Clin. Infect. Dis. pmid:9114144
Woodle ES et al. Reversal of accelerated renal allograft rejection with FK 506. 1997 Clin Transplant pmid:9267710
Eum SY et al. Inhibition by the immunosuppressive agent FK-506 of antigen-induced airways eosinophilia and bronchial hyperreactivity in mice. 1997 Br. J. Pharmacol. pmid:9117088
Ahsan N et al. Pure red cell aplasia due to parvovirus B19 infection in solid organ transplantation. 1997 Clin Transplant pmid:9267713
Jacobson PA et al. Stability of tacrolimus in an extemporaneously compounded oral liquid. 1997 Am J Health Syst Pharm pmid:9117806
Singh N et al. Bloodstream infections in liver transplant recipients receiving tacrolimus. 1997 Clin Transplant pmid:9267715
Guo Z et al. In vivo effects of leflunomide on normal pancreatic islet and syngeneic islet graft function. 1997 Transplantation pmid:9075844
Gruessner RW Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group. 1997 Clin Transplant pmid:9267719
Ciancio G et al. Use of intravenous FK506 to treat acute rejection in simultaneous pancreas-kidney transplant recipients on maintenance oral FK506. 1997 Transplantation pmid:9075856
Sherrington PD et al. TLiSA1 (PTA1) activation antigen implicated in T cell differentiation and platelet activation is a member of the immunoglobulin superfamily exhibiting distinctive regulation of expression. 1997 J. Biol. Chem. pmid:9268302
Mirza DF et al. Reduced acute rejection after liver transplantation with Neoral-based triple immunosuppression. 1997 Lancet pmid:9078209
Danovitch GM Cyclosporin or tacrolimus: which agent to choose? 1997 Nephrol. Dial. Transplant. pmid:9269630
Yoshikawa H et al. FK506 prevents induction of rat experimental autoimmune myasthenia gravis. 1997 J. Autoimmun. pmid:9080295
Talbot D et al. Alopecia as a consequence of tacrolimus therapy in renal transplantation? 1997 Transplantation pmid:9415574
Nagai H et al. FK-506 and cyclosporin A potentiate the IgE antibody production by contact sensitization with hapten in mice. 1997 J. Pharmacol. Exp. Ther. pmid:9336339
Seifeldin RA et al. Nifedipine interaction with tacrolimus in liver transplant recipients. 1997 Ann Pharmacother pmid:9161650
Homey B et al. A local lymph node assay to analyse immunosuppressive effects of topically applied drugs. 1997 Eur. J. Pharmacol. pmid:9163567
Klupp J et al. Mycophenolate mofetil added to immunosuppression after liver transplantation--first results. 1997 Transpl. Int. pmid:9163864
McKee M et al. Initial experience with FK506 (tacrolimus) in pediatric renal transplant recipients. 1997 J. Pediatr. Surg. pmid:9165452
Uno T et al. The pharmacokinetics of water-in-oil-in-water-type multiple emulsion of a new tacrolimus formulation. 1997 Lipids pmid:9168461
Jiang H et al. Distinct tissue and cellular distribution of two major isoforms of calcineurin. 1997 Mol. Immunol. pmid:9393969
Schweda F et al. Tacrolimus treatment for steroid- and cyclosporin-resistant minimal-change nephrotic syndrome. 1997 Nephrol. Dial. Transplant. pmid:9394341
Sabatini DM et al. Neural roles of immunophilins and their ligands. 1997 Mol. Neurobiol. pmid:9396011
Ballantyne CM et al. Pathophysiology and treatment of lipid perturbation after cardiac transplantation. 1997 Curr. Opin. Cardiol. pmid:9192484
Gruessner RW and Sharp HL Living-related intestinal transplantation: first report of a standardized surgical technique. 1997 Transplantation pmid:9415566
Ilan Y et al. Transient immunosuppression with FK506 permits long-term expression of therapeutic genes introduced into the liver using recombinant adenoviruses in the rat. 1997 Hepatology pmid:9328318
Vella JP and Sayegh MH Maintenance pharmacological immunosuppressive strategies in renal transplantation. 1997 Postgrad Med J pmid:9338020
Gruessner AC and Sutherland DE Pancreas transplants for United States (US) and non-US cases as reported to the International Pancreas Transplant Registry (IPTR) and to the United Network for Organ Sharing (UNOS). 1997 Clin Transpl pmid:9919390
Odorico JS et al. Advances in pancreas transplantation: the University of Wisconsin experience. 1997 Clin Transpl pmid:9919400
Katznelson S et al. Clinical aspects of sensitization. 1997 Clin Transpl pmid:9919412
Nair SC et al. Molecular cloning of human FKBP51 and comparisons of immunophilin interactions with Hsp90 and progesterone receptor. 1997 Mol. Cell. Biol. pmid:9001212
Pirenne J et al. Donor-specific unmodified bone marrow transfusion does not facilitate intestinal engraftment after bowel transplantation in a porcine model. 1997 Surgery pmid:9001555
Felldin M et al. Rescue therapy with tacrolimus (FK 506) in renal transplant recipients--a Scandinavian multicenter analysis. 1997 Transpl. Int. pmid:9002146
Becker G et al. Rescue therapy with tacrolimus in simultaneous pancreas/kidney transplantation. 1997 Transpl. Int. pmid:9002152
Odom A et al. The immunosuppressant FK506 and its nonimmunosuppressive analog L-685,818 are toxic to Cryptococcus neoformans by inhibition of a common target protein. 1997 Antimicrob. Agents Chemother. pmid:8980772
Tsamandas AC et al. Adult heart transplantation under tacrolimus (FK506) immunosuppression: histopathologic observations and comparison to a cyclosporine-based regimen with lympholytic (ATG) induction. 1997 J. Heart Lung Transplant. pmid:9257254
Trede NS et al. Tacrolimus (FK506) in allogeneic bone marrow transplantation for severe aplastic anemia following orthotopic liver transplantation. 1997 Bone Marrow Transplant. pmid:9257897
Freiberg RA et al. Transcriptional control in keratinocytes and fibroblasts using synthetic ligands. 1997 J. Clin. Invest. pmid:9169490
Wang JH and Kelly PT Postsynaptic calcineurin activity downregulates synaptic transmission by weakening intracellular Ca2+ signaling mechanisms in hippocampal CA1 neurons. 1997 J. Neurosci. pmid:9169521
Dodd DA Rapid resolution of gingival hyperplasia after switching from cyclosporine A to tacrolimus. 1997 J. Heart Lung Transplant. pmid:9171281
Savoldi E et al. [Dental and oral aspects in pediatric liver transplant patients. A comparison between the effects of cyclosporine A and FK 506]. 1997 Minerva Stomatol pmid:9173223
Rezeig MA et al. Kaposi's sarcoma in liver transplant recipients on FK506: two case reports. 1997 Transplantation pmid:9175820
Aoki Y and Kao PN Cyclosporin A-sensitive calcium signaling represses NFkappaB activation in human bronchial epithelial cells and enhances NFkappaB activation in Jurkat T-cells. 1997 Biochem. Biophys. Res. Commun. pmid:9177287